Subscription
Last updated on 24-Jun-2025 10:55:04
| Category | Offered | Applied | Times |
|---|---|---|---|
| QIBs | 4262627 | 0 | 0 |
| HNIs | 3196970 | 32782 | 0.01 |
| HNIs 10+ | 2131313 | 15207 | 0.01 |
| HNIs 2+ | 1065657 | 17575 | 0.02 |
| Retail | 7459596 | 296629 | 0.04 |
| Total | 14919193 | 329411 | 0.02 |
Application-Wise Breakup (Approx. no. of Apps) | |||
|---|---|---|---|
| Category | Reserved | Applied | Times |
| HNIs (10L+) | 4115 | 5 | 0 |
| HNIs (2-10L) | 2057 | 22 | 0.01 |
| Retail | 201611 | 6089 | 0.03 |
| Subscription Demand (in ₹ crore) | |||
|---|---|---|---|
| Category | Offered | Demand | Times |
| QIBs | 170.51 | 0 | 0 |
| FIIs | - | 0 | - |
| DIIs | - | 0 | - |
| Mutual funds | - | 0 | - |
| Others | - | 0 | - |
| HNIs | 127.88 | 1.31 | 0.01 |
| HNIs 10+ | 85.25 | 0.61 | 0.01 |
| HNIs 2+ | 42.63 | 0.7 | 0.02 |
| Retail | 298.38 | 11.87 | 0.04 |
| Total | 596.77 | 13.18 | 0.02 |
About
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
| Retail | 1 | 37 | 14800 | 201611 |
| sHNI | 14 | 518 | 207200 | 2057 |
| bHNI | 68 | 2516 | 1006400 | 4115 |
IPO Details
| Total Issue Size | [21313130] shares (aggregating up to [852.53] Cr) |
| Fresh Issue | [10000000] shares(aggregating up to 400.00 Cr) |
| Offer for Sale | 11313130 shares of 2 (aggregating up to [452.53] Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Share Holding Pre Issue | 13,09,35,600 shares |
| Share Holding Post Issue | 14,09,35,600 shares |
IPO Reservation
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not more than 50% of the Offer |
| Retail Shares Offered | Not less than 35% of the Offer |
| NII (HNI) Shares Offered | Not less than 15% of the Offer |
Key Performance Indicators
| KPI | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|
| ROE | 16.88% | 11.05% | 7.75% |
| ROCE | 13.71% | 10.93% | 6.07% |
| D/E | 0.32 | 0.15 | 0.01 |
| RONW | 24.97% | 18.10% | 13.84% |
| EPS (basic) | 6.36 | 3.46 | 2.15 |
| P/E Pre IPO | 62.88 | ||
| P/E Post IPO | 67.69 |
Financial Details In Crores
| Period Ended | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|
| Assets | 846.0 | 672.5 | 551.3 |
| Revenue | 348.4 | 290.2 | 223.7 |
| Profit After Tax | 83.3 | 45.3 | 28.1 |
| EBITDA | 109.7 | 61.5 | 33.6 |
| Net Worth | 333.6 | 250.2 | 203.3 |
| Reserves and Surplus | 467.2 | 403.4 | 356.5 |
| Total Borrowing | 245.3 | 176.9 | 101.1 |
About Company
Founded in 1973, EIGL is a leading Indian manufacturer and supplier of industrial, medical, and specialty gases, including oxygen, nitrogen, carbon dioxide, acetylene, argon, helium, hydrogen, and nitrous oxide. The company also offers dry ice, synthetic air, LPG, welding mixtures, and medical-grade gases.
Key Services
- Turnkey project execution for air separation units (ASUs)
- Medical gas pipeline installations and maintenance
- Supply of medical equipment like ventilators, anesthesia workstations, and monitors
Customer Segments
- Bulk – Liquefied gases via cryogenic tankers
- Packaged – Gases in cylinders
- Onsite – End-to-end gas supply with O&M services
Industries Served
EIGL caters to steel, pharmaceuticals, chemicals, healthcare, engineering, railways, aviation, petrochemicals, and defense sectors. Key clients include Dr. Reddy’s, AIIMS, Laurus Labs, and Rashtriya Ispat Nigam.
Operations Snapshot (FY24)
- Customers: 1,836 served
- Bulk Clients: 295 (avg. 5-year contracts)
- Facilities: 8 plants (West Bengal - 4, Andhra Pradesh - 2, Telangana - 1, Chhattisgarh - 1)
- Employees: 250 permanent, 67 contractual
Strength
Diverse Product Range: Wide portfolio of industrial, medical, and specialty gases serving multiple sectors.
Strong Industry Position: Established player with decades of operational experience and nationwide manufacturing presence.
Stable Customer Base: Long-term contracts with marquee clients ensure recurring revenue and cash flow visibility.
Weakness
Customer Concentration Risk: Loss or reduced demand from key customers could significantly impact revenue and cash flows
Operational Disruptions: Unplanned downtime or disruptions at manufacturing facilities may hinder production and affect financial performance.
Onsite Facility Dependence: Operating facilities at customer locations ties operations to client relationships, increasing dependency and risk.
Address
Ellenbarrie Industrial Gases Limited
3A, Ripon Street,
West Bengal, India
Kolkata, West Bengal, 700016
Phone: 033-48226521
Email: complianceofficer@ellenbarrie.com
Website: http://www.ellenbarrie.com/